Jul 12, 2019
Chemotherapy, aka chemo, is a treatment procedure that is used to treat cancer by using anti-cancer drugs. The treatment aims to stop or kill the cancer cells as well as the fast-growing cells while causing the least possible damage to the normal cells.

Pune, India - July 12, 2019 /MarketersMedia/ —
According to the analysis offered by Market Research Future (MRFR), The Global Chemotherapy Market is Expected to register a CAGR of 11.50% to reach USD 56,491.59 Million by 2024.
Chemotherapy is one of the types of cancer treatment, which includes the use of one or more chemotherapeutic agents such as anti-cancer drugs. The treatment prevents the division of cancer cells and the growth of cancer cells by killing dividing cells. It is used for the treatment of various types of cancers such as lung cancer, breast cancer, leukemia, myeloma, sarcoma, lymphoma, ovarian cancer, and others.
Free Sample Copy available @ https://www.marketresearchfuture.com/sample_request/5791
The increasing prevalence of cancer, increasing expenditure on oncology medicine and research, and reimbursements and growing health insurance are driving the growth of the global chemotherapy market.
Market Dynamics
The global chemotherapy market has been largely benefited by the increasing demand for chemotherapy products across the world. Increasing prevalence of cancer; increasing expenditure on oncology medicine and research, and reimbursements and growing health insurance are expected to spur market growth during the forecast period. Moreover, the patent expiry of leading drugs, government initiatives, and increasing public awareness about various diseases and treatment options are further expected to boost the growth of the global chemotherapy market during the review period.
Segmentation
The Global Chemotherapy has been segmented into major four segments, including drug class, route of administration, indication, and end user.
On the basis of drug class, the market is segmented into alkylating agents, mitotic inhibitors, antimetabolites, topoisomerase inhibitors, and antitumor antibiotic. The alkylating agents segment is expected to lead the market and register a substantial CAGR to reach USD 20,360.32 million by the end of 2024 and projected to exhibit the highest CAGR of 11.83% from 2019 to 2024.
Furthermore, based on indication, the market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, lymphoma, leukemia, ovarian cancer, and others. Lung cancer accounted for the largest market share and expected to grow with the CAGR of 11.88% during the forecast period.
On the basis of route of administration, the market is segmented into intravenous, oral, subcutaneous, intra-muscular, intravesicular, topical, intraperitoneal, and intraventricular/intrathecal. Intravenous accounted for the largest market share. However, the oral segment is expected to grow at the fastest CAGR of 11.95% during the forecast period.
On the basis of end user, the market is segmented into, specialty centers, hospitals & clinics, others
Key Players
The prominent players in the global chemotherapy market are Johnson & Johnson Services Inc (US), GlaxoSmithKline PLC (UK), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Pfizer Inc. (US), Merck & Co. Inc. (US), Sanofi S.A. (France), Celgene Corporation (US) and Bristol-Myers Squibb Company (US).
Regional Analysis
Geographically the chemotherapy market is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Americas accounted for the largest market share of 41.04% in 2018, and the regional market is projected to register a CAGR of 10.88%during the forecast period. North America is one of the leading markets in the region, accounting for the largest market share during the review period.
The European market is estimated to exceed USD 18,292.73 Million by 2024. The accessibility to advanced treatment facilities, rising government initiatives to promote research to find a cure to the increasing number of cancer cases, and growing healthcare expenditure are driving the growth of the chemotherapy market in the region. Germany is the major contributor to the growth of the regional market, followed by France.
The market in Asia-Pacific is expected to be the fastest growing market. This high growth is mainly attributed to the increasing R&D funding by developing countries such as China and India for the development of the healthcare sector. Various other factors that influence the growth of the market include growing incidence of cancer, aging population, increasing demand for advanced therapies, patent expiry of leading drugs, government initiatives, and increasing public awareness about various diseases and treatment options.
The Middle East & Africa commands the least market share of the chemotherapy market, owing to fewer developments and extremely low income but, is expected to grow with better chemotherapy treatments. As the population is rapidly aging, cancer treatment is expected to increase in this region
Browse Premium Research with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/chemotherapy-market-5791
Detailed Table of Contents:
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
5 Global Chemotherapy Market, By Material
5.1 Introduction
5.1.1 Synthetic Materials
5.1.2 Genetically Engineered Materials
5.1.3 Biologically Derived Materials
5.1.4 Others
...TOC Continued!
Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/5791
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/chemotherapy-market-5791
Source: MarketersMedia
Release ID: 88895840
Chinese scientists are less satisfied with their jobs than researchers in any other major country, according to a survey that also found they are more optimistic about their careers than their counterparts in the United States and Britain. Only 51 per cent of the 157 respondents from China said they were satisfied with their jobs, according to the survey published this month in the British scientific journal Nature, down 24 per cent from 2018. The survey drew 3,882 respondents from 133...
In September, Chief Executive John Lee Ka-chiu unveiled the city’s first five-year plan along with his policy address, highlighting Hong Kong’s strategic role in promoting the greater use of the yuan outside mainland China as a key priority. In the last of a four-part series on the internationalisation of the yuan, Lam Ka-sing examines Hong Kong’s push to make the currency part of everyday life – from vending machines and retail payments to government spending and cross-border trade. At Hong...
The economy grew 3.4 percent in the third quarter, the fastest pace in a year. Strong spending and growth contrast with the poor marks many voters are giving the economy.
Hundreds lined up along the platform for the first train, which arrived at 4.04am.to pick up train enthusiasts, politicians and those who had played a key role in its construction. Video: Audrey Richardson
Two years ago, Mike Rogers stood before the Republican National Convention and warned that it was “impossible to build an EV without getting into bed with the Communist Party of China”. The former US House Intelligence Committee chairman made opposition to Chinese investment a prominent theme of his 2024 Senate bid in Michigan, which he narrowly lost to Democrat Elissa Slotkin. Now, as Rogers runs again, US President Donald Trump’s softer approach towards Beijing has given candidates more room...
A Chinese businesswoman who had a close relationship with Nvidia chief Jensen Huang was suspected of passing intelligence to Beijing. Donald Trump’s reaction is under scrutiny.
Enormous waves and record-breaking tides are flooding the Southland's restaurants and bars. Forecasts predict more El Niño-driven storms in the coming months.
Federal prosecutors issued criminal grand jury subpoenas to three L.A. County election officials, demanding they appear in court the day after the election.
The opening of the final stretch of the M1 metro line in the early hours of Friday marks a new chapter in the long history of Sydney’s train network.
Police have released the description of a man they believe can assist with their inquiries after a woman was sexually touched during a jog in Bondi on Thursday morning.
Mushroom murderer Erin Patterson will learn today whether her convictions will stand or if she'll face a retrial.
The wait for south-west Sydney commuters is over, with today's opening of the Metro rail line.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.